Next Article in Journal
Hypoxia-Induced FAM13A Regulates the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells
Next Article in Special Issue
Multiple-Cycle Polymeric Extracellular Vesicle Precipitation and Its Evaluation by Targeted Mass Spectrometry
Previous Article in Journal
Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro
Previous Article in Special Issue
Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases
 
 
Review
Peer-Review Record

The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction

Int. J. Mol. Sci. 2021, 22(9), 4301; https://doi.org/10.3390/ijms22094301
by Abdelnaby Khalyfa 1,* and David Sanz-Rubio 2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2021, 22(9), 4301; https://doi.org/10.3390/ijms22094301
Submission received: 7 March 2021 / Revised: 15 April 2021 / Accepted: 16 April 2021 / Published: 21 April 2021
(This article belongs to the Special Issue Exosomes)

Round 1

Reviewer 1 Report

The manuscript entitled „The mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction” reviews available literature of red blood cells and their extracellular vesicles on metabolic dysfunction in OSA patients.

I congratulate the authors on this in-depth review. They in great detail describe the undertaken topic. It provides the reader with an easy-to-follow analysis red blood cells extracellular vesicles in sleep apnea with metabolic dysfunction.

However, throughout the manuscript I think the discussion of hypoxia-inducible factor 1 (HIF-1) is missing considering its great effect on the metabolism of OSA patients and erythrocytes themselves.  It is highly involved in mediating development and progression of DM2 though hypoxia (doi: 10.3389/fphys.2020.01035). While authors describe the comorbidities, especially effects of IH on blood cells HIF-1 is also highly involved (doi: 10.3389/fneur.2018.00635). Furthermore, while discussing reaction of erythrocytes to hypoxia and their further effects it is important to mention that HIF-1 causes upregulation of erythropoietin (EPO) and is a critical factor responsible for increased production of red blood cells. Therefore, it should not be overlooked how HIF-1 is increased in OSA patients (doi: 10.5664/jcsm.8682, doi: 10.17305/bjbms.2016.1579, doi: 10.20452/pamw.15104, doi: 10.3390/jcm9051599, doi: 10.1111/jsr.12995).

 

 

Author Response

Dear Reviewer,

We thank you for your comments and suggestions about HIF.  We integrated our responses in the manuscript, and they're highlighted in Red color. 

Best regards

Khalyfa

Furthermore, another proposed molecular mechanism is hypoxia-inducible factor 1 (HIF-1α) which is based on the oxygen-sensitive α-subunit of HIF-1α -a key regulator of oxygen metabolism which plays an important role in OSA and metabolic dysfunction [44]. It has been indicated that HIF-1 is highly involved in mediating the development and progression of type 2 diabetes ((T2DM) through hypoxia [44]. In addition, HIF-1 is involved in the effects of IH on blood cells [45]. Several studies in OSA animal and cell models have been shown an increased expression of HIF-1a [46, 47]. Other investigations showed that OSA patients increased HIF-1a levels in comparison to healthy control [48-52].

Thus, HIF-1 may cause upregulation of erythropoietin (EPO) and is a critical factor responsible for increased production of red blood cells [84].

Reviewer 2 Report

The manuscript entitled “The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction” is an interesting literature review integrating pathological features from obstructive sleep apnea syndrome and cardiovascular comorbidities with the metabolic consequences of endothelial dysfunction to the molecular aspects with extracellular vesicles of RBCs. Being not particularly familiar with the more molecular aspects, I find this paper interesting bridging molecular aspects and clinical applications. It has a high pedagogic value describing this issue in a comprehensive way for a non-specialist and with the use of accessible illustrations that are complementary. The organization of this paper into 14 sections seems a non-optimal structure and it could benefit to organize some of the chapters into regrouping subheadings (the more pathological clinical aspects, metabolic consequences, RBS, EV and perspectives).

Author Response

Dear Reviewer,

We thank you for your suggestions about combined some sections together due to the length of the mansucrpt. We changed as suggested. 

Best Regards

Khalyfa

 

Back to TopTop